Company plans to use funding for clinical trials of its oral treatment for Chron’s disease.
|
Freescale bets on MRAM to beat out memory contenders.
|
A booming IPO market has helped to fuel interest in venture capital.
|
France’s Emailvision hopes to double its European market share.
|
International venture capital firm backs an Israeli security startup.
|
Exciting events in high-tech business.
|
Venture capitalists at Partech International discuss globalization and its effect on Silicon Valley.
|
Venture capitalists say IPO contracts are becoming more restrictive with lockups requiring them to hold onto shares.
|
Three weeks before its quarterly earnings call, security vendor Tumbleweed names software exec its new CEO.
|
Venture firms in Europe triple fundraising for investment while U.S. fundraising drops 44 percent.
|
Cancer researcher Diatos is a good sign for Europe’s biotech industry.
|
To stop the flow of Nasdaq-bound European startups, the Continent’s patchwork stock markets are finally coming together.
|